Nucleotides, ATP & Energy Currency

When most students think of nucleotides, they think of DNA and RNA. But nucleotides do far more — they are the universal energy currency of all living cells, the cofactors that drive metabolic reactions, and essential signalling molecules. Understanding nucleotides is understanding how every cell generates and spends energy. Structure of a nucleotide: Every nucleotide has three components: 1. A nitrogenous base (one of five: adenine, guanine, cytosine, thymine, uracil) 2. A pentose sugar (ribose in RNA/energy carriers; deoxyribose in DNA) 3. One to three phosphate groups The number of phosphate groups changes the function dramatically: - Monophosphate (NMP) — building block role (in DNA/RNA) - Diphosphate (NDP) — intermediate in energy transfer - Triphosphate (NTP) — the energy-rich, reactive form ATP: Adenosine Triphosphate — the universal energy carrier: ATP is the most important small molecule in biology. It is the direct energy currency used by every enzyme that needs energy. The cell cannot use glucose or fat directly to power its machines — it must first convert the energy in these fuels into ATP. The key is the terminal phosphoanhydride bond — the bond between the second and third phosphate groups. When this bond is hydrolysed: ATP + H₂O → ADP + Pᵢ + ~30.5 kJ/mol of free energy This energy is coupled to endergonic (energy-consuming) reactions to make them proceed spontaneously. The cell uses about 40 kg of ATP per day — yet only contains about 250g of ATP at any time. This means each ATP molecule is recycled approximately 160 times per day.

The body has three systems for regenerating ATP from ADP, operating over different timescales: 1. Phosphocreatine (PCr) system — immediate (0–10 seconds): Creatine phosphate stored in muscle can donate its phosphate directly to ADP: PCr + ADP → Cr + ATP (catalysed by creatine kinase) This is the fastest system — no metabolism needed, just a direct phosphate transfer. Provides energy for explosive bursts (100m sprint, heavy weightlifting). PCr reserves are exhausted in 5–10 seconds. Creatine kinase (CK) is released when muscle is damaged — elevated CK in blood is a marker of muscle injury. CK-MB (the cardiac isoform) rises in myocardial infarction; total CK rises in rhabdomyolysis (muscle destruction from crush injury, statin toxicity, or extreme exercise). 2. Anaerobic glycolysis — fast (10 seconds to 2 minutes): Glucose → 2 pyruvate → 2 lactate Net: 2 ATP per glucose (very low yield) Does NOT require oxygen. Lactate accumulates → muscle burning, acidosis. Provides energy for activities like 400m running. 3. Oxidative phosphorylation — sustained (2 minutes onwards): The dominant system during rest and moderate exercise. Glucose (and fat) are fully oxidised via glycolysis → Krebs cycle → ETC → ~30–32 ATP per glucose. Requires a steady oxygen supply. The Krebs cycle as an ATP generator: Each turn of the Krebs cycle produces: - 3 NADH (each → ~2.5 ATP in the ETC) - 1 FADH₂ (→ ~1.5 ATP in the ETC) - 1 GTP (directly equivalent to 1 ATP) - 2 CO₂ (waste, exhaled) From one glucose: glycolysis (2 ATP + 2 NADH) + 2 turns of Krebs + ETC ≈ 30–32 ATP total Fat yields more ATP than carbohydrate: One palmitate (16-carbon fatty acid) → via beta-oxidation → 8 acetyl-CoA → Krebs + ETC ≈ 106 ATP. Fat is more energy-dense because it is more reduced (more C-H bonds to oxidise). This is why fat contains 9 kcal/g vs 4 kcal/g for carbohydrate.

ATP is not the only energy-carrying nucleotide — several others play key roles in specific metabolic pathways: GTP (Guanosine Triphosphate): - Produced directly in the Krebs cycle (by succinyl-CoA synthetase) - Essential for protein synthesis (powers ribosome translocation during translation) - The substrate for G proteins — GTP binding activates G proteins; hydrolysis to GDP switches them off (the molecular timer for cell signalling) UTP (Uridine Triphosphate): - Essential for glycogen synthesis — glucose-1-phosphate is activated by UTP → UDP-glucose before being added to the glycogen chain by glycogen synthase - Also activates sugars for glycoprotein and glycolipid synthesis CTP (Cytidine Triphosphate): - Key in phospholipid synthesis — activates head groups and diacylglycerol for phospholipid assembly NAD⁺ and FAD — the electron carriers: These are also derived from B vitamins (NAD⁺ from niacin/B3; FAD from riboflavin/B2). They are not used as energy currency directly — instead they transfer electrons between metabolic reactions: - NAD⁺ + 2H⁺ + 2e⁻ → NADH + H⁺ (reduction — gaining electrons = storing energy) - FAD + 2H⁺ + 2e⁻ → FADH₂ (same principle) NADH and FADH₂ carry electrons to the ETC, where they are used to pump H⁺ across the inner mitochondrial membrane, generating the proton gradient used by ATP synthase. The proton motive force: The ETC pumps H⁺ (protons) from the mitochondrial matrix into the intermembrane space, creating an electrochemical gradient (both electrical and chemical components). This gradient is the "proton motive force" — the stored energy that drives ATP synthase (Complex V): - H⁺ flows back through ATP synthase (down the gradient) → rotates the enzyme like a turbine → ADP + Pᵢ → ATP - This is called chemiosmosis — Mitchell's chemiosmotic theory (Nobel Prize, 1978) - Approximately 3 H⁺ per ATP synthesised Uncouplers: Compounds that dissipate the proton gradient without making ATP — causing the mitochondria to "idle" and generate heat instead. Dinitrophenol (DNP) was used as a weight-loss drug in the 1930s — it uncoupled oxidative phosphorylation, causing weight loss but also fatal hyperthermia. Brown adipose tissue (BAT) uses a natural uncoupler protein (UCP1/thermogenin) to generate body heat — important in newborns and in cold acclimatisation.

Nucleotide bases are divided into two structural families: - Purines — double-ring structure: Adenine (A) and Guanine (G) - Pyrimidines — single-ring structure: Cytosine (C), Thymine (T), Uracil (U) De novo synthesis vs salvage: Nucleotides can be synthesised from scratch (de novo synthesis) using amino acids, ribose-5-phosphate (from the pentose phosphate pathway), CO₂, and folate as raw materials — an energy-expensive process. Alternatively, free bases from nucleotide degradation can be recycled (salvage pathway) — much more efficient. Uric acid — the end product of purine degradation: In humans, purines (A and G) are ultimately degraded to uric acid: AMP → IMP → hypoxanthine → xanthine → uric acid (via xanthine oxidase) GMP → guanine → xanthine → uric acid Uric acid has very low solubility in water. When uric acid levels in blood exceed ~6.8 mg/dL, crystals of monosodium urate can precipitate in joints — causing gout. Gout: An intensely painful inflammatory arthritis caused by urate crystal deposition — especially in the big toe (podagra), ankles, and knees. Urate crystals are needle-shaped and trigger a massive neutrophil response when phagocytosed → intense inflammation. - Causes of elevated uric acid: high purine diet (red meat, shellfish, alcohol — especially beer), diuretics, chronic kidney disease, rapid cell turnover (leukaemia, chemotherapy) - Treatment: - Acute attack: colchicine (blocks neutrophil migration), NSAIDs, corticosteroids - Long-term prevention: allopurinol (inhibits xanthine oxidase → less uric acid production) or febuxostat (same mechanism) Lesch-Nyhan syndrome: A rare X-linked disorder caused by deficiency of HGPRT (hypoxanthine-guanine phosphoribosyltransferase) — a key salvage pathway enzyme. Without HGPRT, purines cannot be recycled → massive uric acid overproduction → severe gout + neurological features (self-mutilation, intellectual disability, spasticity). Demonstrates that the salvage pathway is not a luxury — it is essential in the brain. The pentose phosphate pathway (PPP): Runs parallel to glycolysis. Uses glucose-6-phosphate to generate: 1. Ribose-5-phosphate — the sugar backbone for all nucleotides 2. NADPH — the reducing agent needed for fatty acid synthesis, cholesterol synthesis, and neutralising reactive oxygen species via glutathione reductase G6PD deficiency — glucose-6-phosphate dehydrogenase deficiency (the first enzyme of the PPP) — reduces NADPH production → red blood cells cannot neutralise oxidative stress → haemolysis triggered by oxidative insults (certain drugs, fava beans, infection). One of the most common enzyme deficiency disorders worldwide (prevalent in malaria-endemic regions — G6PD-deficient red blood cells are less hospitable to malaria parasites).

Understanding ATP metabolism is directly clinically relevant — many diseases, poisons, and drugs work precisely at the level of energy production. Mitochondrial diseases: Mutations in mitochondrial DNA (mtDNA) or nuclear DNA encoding mitochondrial proteins cause impaired oxidative phosphorylation. Tissues with the highest ATP demand are most affected: brain, muscle, heart. - MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) — strokes in young patients without vascular risk factors; lactic acidosis - MERRF (Myoclonic Epilepsy with Ragged Red Fibres) — epilepsy, muscle weakness - Inheritance: mitochondrial DNA is inherited only from the mother (mitochondria in sperm are destroyed at fertilisation). Mitochondrial diseases are therefore maternally inherited. Ischaemia and ATP depletion: This underlies the mechanism of damage in heart attacks, strokes, and shock: Low blood flow → low O₂ → ETC stops → no ATP → Na⁺/K⁺-ATPase fails → Na⁺ floods in → cell swells → Ca²⁺ enters → activates destructive enzymes → cell death within minutes in neurons (slower in muscle). This is the fundamental biochemistry behind "time is muscle" (MI) and "time is brain" (stroke). Cyanide and carbon monoxide poisoning: - Cyanide — binds Complex IV (cytochrome c oxidase) irreversibly → electrons cannot pass to O₂ → ETC stops → no ATP → rapid cell death. Treatment: hydroxocobalamin (binds cyanide) + dicobalt edetate - Carbon monoxide — binds haemoglobin with 250× greater affinity than O₂ → carboxyhaemoglobin → tissue hypoxia → also binds mitochondrial cytochrome c oxidase directly. Treatment: 100% O₂ (to displace CO). Statins and CoQ10: Statins inhibit HMG-CoA reductase → less cholesterol. But cholesterol synthesis and ubiquinone (CoQ10) synthesis share the same pathway. CoQ10 (Coenzyme Q) is a critical electron carrier between Complexes I/II and III in the ETC. Statins may reduce CoQ10 levels in some patients → myopathy (muscle pain and weakness). CoQ10 supplementation is used by some patients on statins, though evidence for benefit is mixed. Metformin: The most widely used drug for Type 2 diabetes. One of its mechanisms: inhibits Complex I of the ETC → reduces mitochondrial ATP production in liver → AMPK (AMP-activated protein kinase, the cell's "energy sensor") activated → reduces hepatic gluconeogenesis → lowers blood glucose. Also reduces appetite and has cardiovascular protective effects beyond glucose lowering.